Search

Your search keyword '"Macular degeneration -- Reports"' showing total 762 results

Search Constraints

Start Over You searched for: Descriptor "Macular degeneration -- Reports" Remove constraint Descriptor: "Macular degeneration -- Reports"
762 results on '"Macular degeneration -- Reports"'

Search Results

2. Dry Age Macular Degeneration Pipeline Insights 2024: Therapies, Clinical Trials, Therapies and Key Companies involved by DelveInsight |Janssen R&D, Belite Bio, Katairo, Cognition Therapeutics

3. New Gene Therapy Study Findings Reported from MOE Key Laboratory of Gene Function and Regulation (CRISPR-based gene therapy for wet age-related macular degeneration in mouse model)

6. Findings on Obesity Reported by Investigators at Shanghai First People's Hospital (Fat Mass and Obesity-associated Protein Alleviates Ab1-40 Induced Retinal Pigment Epithelial Cells Degeneration Via Pka/creb Signaling Pathway)

7. New Medical Technology Research Has Been Reported by a Researcher at Queen's University (Home-monitoring for neovascular age-related macular degeneration in older adults within the UK: the MONARCH diagnostic accuracy study)

8. Researchers from University of London Detail Findings in Age-Related Macular Degeneration (Views and opinions of patients with glaucoma and age-related macular degeneration on vision home-monitoring: a UK-based focus group study)

9. Wet Age-Related Macular Degeneration Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | IVERIC bio, Ribomic, Curacle, Bio-Thera

11. Dry Age Macular Degeneration Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight |Janssen Research, Belite Bio, Katairo

12. Dry Age-Related Macular Degeneration Pipeline Insights Report 2024 | Molecular Partners, Stealth BioTherapeutics, Regenerative Patch Technologies, Aevitas Therapeutics, NGM Biopharmaceuticals

13. Automated Visual Field Analyzer Market to See Significant Growth, Forecasts New Report with Insights on Technology Trends by 2030

14. Automated Visual Field Analyzer Market to See Significant Growth, Forecasts New Report with Insights on Technology Trends by 2030

16. New Age-Related Macular Degeneration Findings Reported from University of North Carolina Chapel Hill (Intracellular Trafficking Pathway and Ros Scavenging Activity of Glycol Chitosan-coated Cerium Oxide Nanoparticles In a Pathological Amd-like ...)

18. Researchers from Shanghai Jiao Tong University School of Medicine Publish Findings in Liposomes (Novel therapeutic perspectives for wet age-related macular degeneration: RGD-modified liposomes loaded with 2-deoxy-D-glucose as a promising ...)

19. SEC asks Emcure, Sandoz to submit more data for further approval of ophthalmic injections

20. SEC asks Emcure, Sandoz to submit more data for further approval of ophthalmic injections

21. Dry Age-Related Macular Degeneration Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023

22. Ocular Drug Delivery Market to reach $115.5 Billion, Globally, by 2032 at 5.5% CAGR: Allied Market Research

23. Data on Age-Related Macular Degeneration Published by a Researcher at Kuwait University (Enhancing Readability and Detection of Age-Related Macular Degeneration Using Optical Coherence Tomography Imaging: An AI Approach)

24. Reports from Lixiang Eye Hospital of Soochow University Describe Recent Advances in Choroidal Neovascularization (Tocilizumab attenuates choroidal neovascularization by regulating macrophage polarization through the IL-6R/STAT3/VEGF pathway)

25. Reports Summarize Ophthalmology Research from Royal Victorian Eye and Ear Hospital (Functional Evaluation of Retinal Pigment Epithelium and Outer Retinal Atrophy by High-Density Targeted Microperimetry Testing)

26. Dry Age Macular Degeneration Clinical Trials | A Drug Pipeline Analysis Report 2023 | Companies-Molecular Partners, Stealth BioTherapeutics

27. Age Related Macular Degeneration Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Amgen, Roche, Adverum Biotechnologies, AsclepiX

28. Dry Age-Related Macular Degeneration Pipeline Insight 2023 (Updated)

29. Vision Health: Clear Opportunities for Market Development: Nutrition has a leading role to play in protecting eyes against modern lifestyle challenges

30. Study Findings from SRM Institute of Science and Technology Broaden Understanding of Age-Related Macular Degeneration (Application Program Interface for Automatic Segmentation of Retinal Layers and Fluids In Optical Coherence Tomography - ...)

31. Research Reports from F. Hoffmann-La Roche Ltd. - Roche Pharma Research and Early Development Provide New Insights into Age-Related Macular Degeneration (Machine Learning to Predict Response to Ranibizumab in Neovascular Age-Related Macular ...)

32. Patent Issued for Oxidative retinal diseases (USPTO 11285125)

33. Retinal Biologics Market to Reach $24.7 Billion, Globally, by 2032 at 5.1% CAGR: Allied Market Research

34. Optometry Equipment Market Research Report 2023 - Industry Size, Current Insights, Future Growth and Development Trends

35. Researchers from Fujian Medical University Union Hospital Detail Findings in Macular Edema (Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization)

36. Investigators from University of California Irvine Report New Data on Cell Biology (Differential Responses of Amd Mitochondrial Dna Haplogroups To Pu-91, a Mitochondria-targeting Drug)

37. Studies Conducted at Massachusetts Institute of Technology on Age-Related Macular Degeneration Recently Published (Ultrahigh Resolution OCT Markers of Normal Aging and Early Age-related Macular Degeneration)

38. Data from Kyungpook National University Broaden Understanding of Antioxidants (Sulforaphane Alleviates Particulate Matter-Induced Oxidative Stress in Human Retinal Pigment Epithelial Cells)

39. Clearside report 'positive' safety results from OASIS Phase 1/2a trial of CLS-AX

42. Wet Age Related Macular Degeneration Pipeline Insight | 70+ Companies and 80+ Pipeline Drugs

43. Wet Age-Related Macular Degeneration Pipeline Insight Report and Clinical Trial Analysis | 70+ Companies and 80+ Drugs

44. Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd

45. Patent Issued for Antibody and protein therapeutic formulations and uses thereof (USPTO 11692027)

46. New Age-Related Macular Degeneration Research from University of Alabama at Birmingham School of Medicine Discussed (Histology, dimensions, and fluorescein staining characteristics of nodular and cuticular drusen in age-related macular ...)

47. Researchers from Doheny Eye Institute Report New Studies and Findings in the Area of Age-Related Macular Degeneration (Drusen Morphometrics On Optical Coherence Tomography In Eyes With Age-related Macular Degeneration and Normal Aging)

48. Study Findings from University of Geneva Provide New Insights into Antioxidants (Mammalian Animal and Human Retinal Organ Culture as Pre-Clinical Model to Evaluate Oxidative Stress and Antioxidant Intraocular Therapeutics)

49. Researchers at University of Bonn Publish New Study Findings on Diagnostics and Screening (Accurate drusen segmentation in optical coherence tomography via order-constrained regression of retinal layer heights)

50. Findings on Age-Related Macular Degeneration Detailed by Investigators at Cleveland Clinic (Identifying Geographic Atrophy)

Catalog

Books, media, physical & digital resources